Tracer library / [111In]In-octreotide
[111In]In-octreotide
Also written as Indium In 111 Pentetreotide; OctreoScan; [111In]In-octreotide; pentetreotide
- Radionuclide
- In-111
- Modality
- —
- Production route
- —
- Stage
- —
- Syntheses indexed
- 3
Published syntheses
| Module | Cassette | Purification | Yield % | RCP % | Precursor / supplier | Source |
|---|---|---|---|---|---|---|
| — | — | — | — | >95% | [DTPA-D-Phe1]-octreotide Covidien | 21170526 2011 Eur J Nucl Med Mol Imaging |
| Manual synthesis | — | — | — | >95% | [DTPA-d-Phe1]-octreotide (Octreoscan) Covidien | 19722105 2010 Eur J Nucl Med Mol Imaging [DTPA-d-Phe1]-octreotide (Octreoscan, Covidien) was labelled with 111In by adding 37 MBq of 111InCl3 (Covidien) to 1 µg of Octreoscan and incubating for 30 min at room temperature. |
| Kit-based preparation | — | — | — | — | DTPA-d-Phe-1-octreotide | 8878464 1996 Jpn J Cancer Res 111In‐octreotide was obtained as a kit |
Precursor
- Common precursor
- —
- Suppliers seen in the literature
- —
- Cited suppliers in indexed syntheses
- Covidien
- Typical final purification
- —
Need this precursor?We can point you to suppliers for [111In]In-octreotide, or handle the enquiry for you.
Get in touchNotes
Added at stage 39 (2026-09-27) from a reverse search of the PubMed corpus's own unattached articles (articles that named a real compound not yet in this reference): 8 article(s) found under this name, not yet individually researched. Target/mechanism, clinical application, indications, approval, modality, stage and production route are intentionally left empty. PMIDs: 7498221, 8878464, 9871736, 11038002, 17707803, 19722105, 21170526, 29201454.